Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Callisto completes patient enrollment in phase II atiprimod trial

Sep. 25, 2007

HE-3235 inhibits growth of MNU-induced breast tumors in rats

Sep. 25, 2007

PTC-299 reduces growth of breast cancer xenografts

Sep. 25, 2007

Survival benefit seen with picoplatin in small cell lung cancer patients

Sep. 25, 2007

The EC to authorize Yondelis commercialization for soft tissue carcinoma

Sep. 21, 2007

Wyeth receives EMEA opinions on Torisel and Mylotarg

Sep. 21, 2007

Lilly files for European approval of Alimta as first-line treatment of NSCLC

Sep. 21, 2007

MKC-1 well tolerated in phase II metastatic breast cancer trial

Sep. 21, 2007

Motexafin gadolinium studied in refractory lung cancer, patients with brain metastases

Sep. 21, 2007

BIBW-2992 active in preclinical models and patients with non-small cell lung cancer

Sep. 21, 2007

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...